Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

CMS proposes Medicare coverage for renal denervation | New echo guidelines | RBM embraces AI-enabled plaque evaluations

News You Need to Know Today
CMS proposes Medicare coverage for renal denervation | New echo guidelines | RBM embraces AI-enabled plaque evaluations
Monday, July 14, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CMS proposes Medicare coverage for renal denervation

This proposal, if finalized, would dramatically increase patient access to renal denervation. Both Recor Medical and Medtronic have shared their excitement over the news.

READ MORE >
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes Medicare coverage for renal denervation

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
This proposal, if finalized, would dramatically increase patient access to renal denervation. Both Recor Medical and Medtronic have shared their excitement over the news.
READ MORE >

ASE shares new recommendations for evaluating LV diastolic function, HFpEF

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

READ MORE >
Agfa automated echo measurements on echo report CVIS at ASE 2023. An updated guideline from the American Society of Echocardiography (ASE) offers new echocardiographic parameters and recommendations for clinicians evaluating patients for possible heart failure. "The Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction (HFpEF) Diagnosis) was published in the July 2025 issue of the Journal of the ASE.
Share on Twitter Share on Facebook Share on Linkedin

ASE shares new recommendations for evaluating LV diastolic function, HFpEF

Share on Twitter Share on Facebook Share on Linkedin
Agfa automated echo measurements on echo report CVIS at ASE 2023. An updated guideline from the American Society of Echocardiography (ASE) offers new echocardiographic parameters and recommendations for clinicians evaluating patients for possible heart failure. "The Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction (HFpEF) Diagnosis) was published in the July 2025 issue of the Journal of the ASE.
The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.
READ MORE >

AI-enabled coronary plaque evaluations included in new RBM guidelines

The use of advanced AI software to assess CCTA images continues to gain more momentum.

READ MORE >
HeartFlow Plaque Analysis Example
Share on Twitter Share on Facebook Share on Linkedin

AI-enabled coronary plaque evaluations included in new RBM guidelines

Share on Twitter Share on Facebook Share on Linkedin
HeartFlow Plaque Analysis Example
The use of advanced AI software to assess CCTA images continues to gain more momentum.
READ MORE >

Featured Articles

Cardiology still No. 2 in FDA-cleared clinical AI algorithms, trailing only radiology

Cardiology continues to be one of the most influential healthcare specialties when it comes to utilizing artificial intelligence. 

READ MORE >
An example of artificial intelligence automated coronary artery calcium scoring shown by Coreline at ACC23. The AI also identifies and color codes the anatomy so help show the reviewing radiologist or cardiac imager what and where things were calculated. #ACC #ACC23
Share on Twitter Share on Facebook Share on Linkedin

Cardiology still No. 2 in FDA-cleared clinical AI algorithms, trailing only radiology

Share on Twitter Share on Facebook Share on Linkedin
An example of artificial intelligence automated coronary artery calcium scoring shown by Coreline at ACC23. The AI also identifies and color codes the anatomy so help show the reviewing radiologist or cardiac imager what and where things were calculated. #ACC #ACC23
Cardiology continues to be one of the most influential healthcare specialties when it comes to utilizing artificial intelligence. 
READ MORE >

Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation

CMS has finalized a new national coverage determination for T-TEER, sometimes known as transcatheter tricuspid valve repair. Abbott's TriClip is the only device approved by the FDA for T-TEER, but other treatment options are under development.

READ MORE >
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
Share on Twitter Share on Facebook Share on Linkedin

Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation

Share on Twitter Share on Facebook Share on Linkedin
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
CMS has finalized a new national coverage determination for T-TEER, sometimes known as transcatheter tricuspid valve repair. Abbott's TriClip is the only device approved by the FDA for T-TEER, but other treatment options are under development.
READ MORE >

Myval TAVR valve associated with positive durability data after 4 years

Researchers have been spending more and more time evaluating the Myval TAVR valve from Indian medtech company Meril Life Sciences. The balloon-expandable device is available in some parts of the world, but not the United States.

READ MORE >
The balloon-expandable Myval transcatheter aortic valve replacement (TAVR) valve is associated with positive real-world data after four years.
Share on Twitter Share on Facebook Share on Linkedin

Myval TAVR valve associated with positive durability data after 4 years

Share on Twitter Share on Facebook Share on Linkedin
The balloon-expandable Myval transcatheter aortic valve replacement (TAVR) valve is associated with positive real-world data after four years.
Researchers have been spending more and more time evaluating the Myval TAVR valve from Indian medtech company Meril Life Sciences. The balloon-expandable device is available in some parts of the world, but not the United States.
READ MORE >

World’s first patient receives new-look heart pump—cardiologist ‘impressed’ by device’s performance

The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 

READ MORE >
CorWave LVAD
Share on Twitter Share on Facebook Share on Linkedin

World’s first patient receives new-look heart pump—cardiologist ‘impressed’ by device’s performance

Share on Twitter Share on Facebook Share on Linkedin
CorWave LVAD
The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 
READ MORE >

In Case You Missed It

TTVR with Evoque system linked to positive real-world outcomes after 30 days

According to early real-world data, the FDA-approved Evoque TTVR device is associated with positive outcomes when used to treat severe tricuspid regurgitation. 

READ MORE >
The Evoque transcatheter tricuspid valve replacement (TTVR) system for tricuspid regurgitation from Edwards Lifesciences. The Evoque is the first transcatheter tricuspid valve approved by the FDA. It is the first TTVR cleared in the U.S.
Share on Twitter Share on Facebook Share on Linkedin

TTVR with Evoque system linked to positive real-world outcomes after 30 days

Share on Twitter Share on Facebook Share on Linkedin
The Evoque transcatheter tricuspid valve replacement (TTVR) system for tricuspid regurgitation from Edwards Lifesciences. The Evoque is the first transcatheter tricuspid valve approved by the FDA. It is the first TTVR cleared in the U.S.
According to early real-world data, the FDA-approved Evoque TTVR device is associated with positive outcomes when used to treat severe tricuspid regurgitation. 
READ MORE >

Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app

The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

READ MORE >
physician acceptance of generative AI
Share on Twitter Share on Facebook Share on Linkedin

Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app

Share on Twitter Share on Facebook Share on Linkedin
physician acceptance of generative AI
The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.
READ MORE >

A closer look at world’s first TAVR patient treated with new cerebral embolic protection device

The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.

READ MORE >
EnCompass F2 device from Nevada-based EnCompass Technologies. (A) Aortic arch deflector composed of a cylindrical nitinol frame that covers all three vessels supplying blood flow to the brain while allowing passage of the transcatheter aortic valve replacement system through its center. (B) It features an electrospun filter with very small pore size (30 μm average). Images/caption courtesy of JACC: Case Reports and George et al.
Share on Twitter Share on Facebook Share on Linkedin

A closer look at world’s first TAVR patient treated with new cerebral embolic protection device

Share on Twitter Share on Facebook Share on Linkedin
EnCompass F2 device from Nevada-based EnCompass Technologies. (A) Aortic arch deflector composed of a cylindrical nitinol frame that covers all three vessels supplying blood flow to the brain while allowing passage of the transcatheter aortic valve replacement system through its center. (B) It features an electrospun filter with very small pore size (30 μm average). Images/caption courtesy of JACC: Case Reports and George et al.
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.
READ MORE >

In Other News

Lehigh Valley Health admits to controlled substances violations in $2.75M settlement

The Pennsylvania-based health system reported drug diversion incidents to authorities involving a pharmacy technician who used employee passwords to steal pills from one of its hospitals.

READ MORE >
Lehigh Valley Hospital
Share on Twitter Share on Facebook Share on Linkedin

Lehigh Valley Health admits to controlled substances violations in $2.75M settlement

Share on Twitter Share on Facebook Share on Linkedin
Lehigh Valley Hospital
The Pennsylvania-based health system reported drug diversion incidents to authorities involving a pharmacy technician who used employee passwords to steal pills from one of its hospitals.
READ MORE >

Sanitation issue forces FDA recall of ventilator suction systems

Ballard Closed Suction Systems will need to be returned to the manufacturer for a refund due to the high risk of a potentially fatal infection stemming from their use.

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

Sanitation issue forces FDA recall of ventilator suction systems

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
Ballard Closed Suction Systems will need to be returned to the manufacturer for a refund due to the high risk of a potentially fatal infection stemming from their use.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Teen's death at center of new lawsuit | Surgery outperforms GLP-1 drugs | Long-term antidepressant use & SCD
AI helps 3D imaging labs evolve | Catheters recalled over safety risk | New ways to predict TAVR outcomes
Looking Back: Cardiologist fired for speaking out | Hospital sues practice | Strokes after PFA | Energy drinks & heart disease
Surgery outperforms GLP-1 drugs | CEPDs fail to make an impact | Redo TAVR: Supra-annular vs. intra-annular valves
Week in Review: FDA clears imaging platform | Vascular device linked to deaths | GLP-1 drugs & AFib | Pacemakers recalled again
Optimism about cardiology’s future | HRS leader looks ahead | Women live longer after TAVR | J&J announces acquisition
Preventing the most common complication after heart surgery | When bioprosthetic valves fail | Good news for Medtronic

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup